Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nicholson

Showing results (341-350 of 361) with videos related to

Pageof 37
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749)N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Medicinal Research Reviews|April 13, 2001
Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonistN S Nicholson, N A Abood, S G Panzer-Knodle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group StudyR J Packer, J Goldwein, H S Nicholson, et al.
The American Journal of Managed Care|November 10, 2009
Effectiveness of care coordination and health counseling in advancing illnessJoseph B Engelhardt, Victoria M Rizzo, Richard D Della Penna, et al.
Plos Biology|July 3, 2025
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunctionAlex S Nicholson, David A Priestman, Robin Antrobus, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2023
Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelinationShannon J McKie, Alex S Nicholson, Emily Smith, et al.
Thrombosis Research|February 18, 2004
Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding timeJames A Szalony, Osman D Suleymanov, Anita K Salyers, et al.
The Journal of Experimental Medicine|May 1, 1996
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosisS Nicholson, M da G Bonecini-Almeida, J R Lapa e Silva, et al.
Nature Communications|March 24, 2026
Antigen-specific immunotherapy with a CD4<sup>+</sup> T cell neoepitope restrains CD8<sup>+</sup> T cell differentiation in murine pancreatic islet graftsJames E DiLisio, K Scott Beard, Tobias Neef, et al.
Pathology|August 20, 2021
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detectionK A Bond, E Williams, S Nicholson, et al.
Pageof 37

Showing results (341-350 of 361) with videos related to

Sort By:
Pageof 37
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749)N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Medicinal Research Reviews|April 13, 2001
Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonistN S Nicholson, N A Abood, S G Panzer-Knodle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group StudyR J Packer, J Goldwein, H S Nicholson, et al.
The American Journal of Managed Care|November 10, 2009
Effectiveness of care coordination and health counseling in advancing illnessJoseph B Engelhardt, Victoria M Rizzo, Richard D Della Penna, et al.
Plos Biology|July 3, 2025
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunctionAlex S Nicholson, David A Priestman, Robin Antrobus, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2023
Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelinationShannon J McKie, Alex S Nicholson, Emily Smith, et al.
Thrombosis Research|February 18, 2004
Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding timeJames A Szalony, Osman D Suleymanov, Anita K Salyers, et al.
The Journal of Experimental Medicine|May 1, 1996
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosisS Nicholson, M da G Bonecini-Almeida, J R Lapa e Silva, et al.
Nature Communications|March 24, 2026
Antigen-specific immunotherapy with a CD4<sup>+</sup> T cell neoepitope restrains CD8<sup>+</sup> T cell differentiation in murine pancreatic islet graftsJames E DiLisio, K Scott Beard, Tobias Neef, et al.
Pathology|August 20, 2021
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detectionK A Bond, E Williams, S Nicholson, et al.
Pageof 37